v3.22.2
Condensed Consolidated Statements of Cash Flows - USD ($)
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net loss $ (43,214,807) $ (164,125,858)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 710,348 787,846
Change in fair value and loss on exchange of convertible notes 1,769,857 (7,000,000)
Change in fair value of Investment in LMC 0 148,305,618
Stock-based compensation 5,642,702 2,032,341
Change in inventory and prepaid purchases reserve 425,130 (7,560,774)
Forgiveness of PPP Term Note 0 (1,411,000)
Deferred taxes 0 (18,914,439)
Non-cash lease expense 583,406 0
Other non-cash items 175,750 0
Effects of changes in operating assets and liabilities:    
Accounts receivable (634,892) (822,445)
Inventory (3,187,163) (26,477,331)
Prepaid expenses and other current assets (7,119,454) (7,499,919)
Other assets (34,401) 0
Accounts payable, accrued liabilities and other (9,317,242) 1,952,104
Warranty liability (1,261,704) (533,787)
Net cash used in operating activities (55,462,470) (81,267,644)
Cash flows from investing activities:    
Capital expenditures (5,658,776) (3,281,213)
Net cash used in investing activities (5,658,776) (3,281,213)
Cash flows from financing activities:    
Proceeds from issuance of common stock 248,695 0
Payments on finance lease (389,780) 0
Exercise of warrants and options and restricted share award activity (324,488) (69,416)
Net cash used in financing activities (465,573) (69,416)
Change in cash and cash equivalents (61,586,819) (84,618,273)
Cash, cash equivalents and restricted cash, beginning of the period 201,647,394 241,229,067
Cash and cash equivalents, end of the period $ 140,060,575 $ 156,610,794

Source